TwinStrand Biosciences
TwinStrand Biosciences develops Duplex Sequencing technology that uses error-corrected DNA sequencing to detect ultra-low-frequency genomic variants missed by conventional next-generation sequencing. Its technology supports researchers studying applications such as residual cancer, mutation signatures and genetic toxicology, with the aim of improving human health and accelerating scientific discovery.
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology Research
- Founded
- 2016 Seattle business license
- Type
- Corporation Seattle business license
- Employees
- 51–200
- Registered name
- TwinStrand Biosciences Inc Seattle business license
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
USPTO Upholds Second UW/TwinStrand Patent, Solidifying $245.2M Award Against Guardant Health
The USPTO upheld the validity of TwinStrand and University of Washington’s second patent in their infringement suit against Guardant Health, cementing a $245.2 million federal-court award that followed a 2023 jury verdict.
Inside the MSTI: Ross Todrzak (MSTI ’22) Says Curiosity and Problem-Focused Learning Shaped His Product Leadership
Ross Todrzak (MSTI ’22) credits the Master of Science in Technology Innovation (MSTI) program with shaping his product leadership by emphasizing that product innovation starts with a meaningful problem to solve.
TwinStrand Biosciences and University of Washington awarded $245.2M in patent verdict against Guardant Health
TwinStrand Biosciences and the University of Washington won a $245.2 million patent infringement judgment against Guardant Health after a federal court preserved a 2023 jury verdict finding Guardant infringed two patents tied to TwinStrand's duplex sequencing technology.
See all 16 stories, episodes and videos about TwinStrand Biosciences.
Seattle Flow is free for everyone.
- Claim and edit your profile
- Get alerts about you, your company, and anything else you care about
- Access the most comprehensive investor list in Seattle
- Join the conversation on news, podcasts, and events
People
-
Jesse Salk Co-founder and CEO -
Ron Andrews Executive, Chief Executive Officer and Director